Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. doi: 10.1002/14651858.CD004185.pub2
Methods Six-week double-blind, randomised study.
Participants Outpatients fulfilling DSM-III criteria for major depression (unipolar), with a score of at least 17 on the HDRS.
Age range: 18-75 years.
Exclusion criteria: significant pohysiacl illness, lactation, pregnancy, history of schizophrenia or drug or alcohol abuse, current use of antidepressant
Interventions Fluoxetine: 30 participants.
Dothiepin: 30 participants.
Fluoxetine dose range: 20-40
Dothiepine dose range: 100-200.
Benzodiazepines were allowed for sedation at the discretion of the doctor
Outcomes Hamilton Rating Scale for Depression, Montgomery and Asberg Scale for Depression (MADRS), CGI Severity and Improvement, PGI
Notes Funding: by industry
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
HHS Vulnerability Disclosure